Recent Updates
Recently added Catalysts
FULC Positive Sentiment Score: 70/100

Fulcrum Therapeutics to Participate at the Cantor Virtual Muscular Dystrophy Symposium

Thursday, March 28, 2024 1 min read
Key Takeaway: Fulcrum Therapeutics, a clinical-stage biopharmaceutical company, will partake in a fireside chat at the Cantor Virtual Muscular Dystrophy Symposium on April 2, 2024. The event aims to engage with stakeholders and share insights related to their development of small molecules for rare diseases. A replay of the presentation will be available on the company's website for at least 30 days post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Fulcrum Therapeutics is engaging with the community through participation in an important symposium.
  • The focus on improving lives for patients with rare diseases highlights their commitment.
  • The availability of a webcast ensures wider accessibility and transparency.

Full Press Release Details

CAMBRIDGE, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in a fireside chat at the Cantor Virtual Muscular Dystrophy Symposium, being held on Tuesday, April 2, 2024 at 10:40 a.m. ET.
The webcast of the presentation will be accessible here and by visiting the "Events and Presentations" section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations. A replay of the webcast will be available on Fulcrum Therapeutics’ website for at least 30 days following the presentation.
About Fulcrum Therapeutics
LifeSci Advisors, LLC
ccalabrese@lifesciadvisors.com

Frequently Asked Questions

What event will Fulcrum Therapeutics participate in?

Fulcrum Therapeutics will participate in the Cantor Virtual Muscular Dystrophy Symposium.

When is Fulcrum Therapeutics' presentation scheduled?

The presentation is scheduled for April 2, 2024, at 10:40 a.m. ET.

Where can I access the webcast of the presentation?

The webcast can be accessed on Fulcrum Therapeutics’ website under

How long will the replay of the webcast be available?

The replay of the webcast will be available for at least 30 days.

What is the focus of Fulcrum Therapeutics?

Fulcrum Therapeutics focuses on developing small molecules for rare diseases.

Tags: FULC Viatris Investor Conferences Healthcare Fulcrum Therapeutics Muscular Dystrophy biopharmaceutical clinical-stage
Last updated: Mar 28, 2024